Myomo MYO
NYSE MYO
$1.71 -0.15 (-8.06%)
At close: Aug 20, 2026 · 1:09 PM UTC

Myomo (MYO) EBIT Margin (2016 - 2025)

Myomo's (MYO) quarterly EBIT Margin came in at 34.86% in Q3 2025, down 2446.0% YoY from 1.49% in Q3 2024, and up 26.7% on a QoQ basis from 47.56% in Q2 2025.

Myomo (MYO) EBIT Margin (2016 - 2025) Analysis & Trends

Myomo (MYO) has 10 years of EBIT Margin data on file, last reported at 34.86% in Q3 2025.

  • Quarterly EBIT Margin fell 2446.0% year-over-year to 34.86% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 28.51% (up 475.0% YoY) and the FY2024 annual result came in at 19.07%, up 2371.0% from the prior year.
  • EBIT Margin grew to 34.86% in Q3 2025, from 47.56% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 2.03% in Q4 2024 to a low of 125.51% in Q1 2021.
  • A 5-year average of 54.45% and a median of 51.16% in 2023 frame the typical range for EBIT Margin.
  • Annual changes were most pronounced in 2021 — EBIT Margin surged 24803 bps — and 2025, when it sank 3273 bps.
  • Tracing MYO's EBIT Margin over 5 years: stood at 67.11% in 2021, then advanced by 18 bps to 55.16% in 2022, then climbed by 7 bps to 51.16% in 2023, then soared by 96 bps to 2.03% in 2024, then plunged by 1615 bps to 34.86% in 2025.
  • The last three EBIT Margin figures came in at 34.86% (Q3 2025), 47.56% (Q2 2025), and 35.8% (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn 13.44%
2 Stryker 128.79 Bn 125.32 Bn 4.50 Bn 25.18%
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn 19.10%
4 Boston Scientific 73.50 Bn 72.96 Bn 3.85 Bn 21.65%
5 Edwards Lifesciences 52.11 Bn 47.86 Bn 1.35 Bn 29.48%
6 Dexcom 34.62 Bn 32.67 Bn 830.00 Mn 24.33%
7 GE HealthCare Technologies 34.05 Bn 31.94 Bn 2.18 Bn 13.96%
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn 10.30%
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 19.15%
10 Myomo 73.16 Mn 54.19 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -34.86%
Jun 30, 2025 -47.56%
Mar 31, 2025 -35.80%
Dec 31, 2024 -2.03%
Sep 30, 2024 -10.40%
Jun 30, 2024 -14.83%
Mar 31, 2024 -103.58%
Dec 31, 2023 -51.16%
Sep 30, 2023 -39.85%
Jun 30, 2023 -18.51%
Mar 31, 2023 -77.49%
Dec 31, 2022 -55.16%
Sep 30, 2022 -71.03%
Jun 30, 2022 -78.74%
Mar 31, 2022 -70.81%
Dec 31, 2021 -67.11%
Sep 30, 2021 -46.31%
Jun 30, 2021 -83.74%
Mar 31, 2021 -125.51%
Dec 31, 2020 -44.50%